{"id":"rescinnamine","rwe":[{"pmid":"35814925","year":"2022","title":"In vitro evaluation of bioactive properties of banana sap.","finding":"","journal":"Biologia","studyType":"Clinical Study"},{"pmid":"34055238","year":"2021","title":"Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.","finding":"","journal":"Computational and structural biotechnology journal","studyType":"Clinical Study"},{"pmid":"33836128","year":"2021","title":"Decomposition Profile Data Analysis for Deep Understanding of Multiple Effects of Natural Products.","finding":"","journal":"Journal of natural products","studyType":"Clinical Study"},{"pmid":"33131412","year":"2022","title":"Unravelling the drugability of MSI2 RNA recognition motif (RRM) protein and the prediction of their effective antileukemia inhibitors from traditional herb concoctions.","finding":"","journal":"Journal of biomolecular structure & dynamics","studyType":"Clinical Study"},{"pmid":"29956574","year":"2020","title":"The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder.","finding":"","journal":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","studyType":"Clinical Study"}],"tags":[{"label":"rescinnamine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Synaptic vesicular amine transporter","category":"target"},{"label":"SLC18A2","category":"gene"},{"label":"C02AA01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Pfizer","category":"company"},{"label":"Approved 1950s","category":"decade"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=RESCINNAMINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:55:54.778648+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Rescinnamine","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T01:56:01.455911+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:55:59.955996+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=RESCINNAMINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:56:00.365845+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Synaptic vesicular amine transporter inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:01.455851+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1668/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:01.082035+00:00"}},"allNames":"moderil","offLabel":[],"synonyms":["rescinnamine","cinnaloid","methyl trimethoxycinnamoylreserpate","rescinnamin","rescisan","resealoid","reserpinine","scinnamina","moderil"],"timeline":[{"date":"1956-10-31","type":"positive","source":"DrugCentral","milestone":"FDA approval (Pfizer)"}],"brandName":"Moderil","ecosystem":[],"mechanism":{"target":"Synaptic vesicular amine transporter","novelty":"Follow-on","targets":[{"gene":"SLC18A2","source":"DrugCentral","target":"Synaptic vesicular amine transporter","protein":"Synaptic vesicular amine transporter"}],"modality":"Small Molecule","drugClass":"rescinnamine","explanation":"","oneSentence":"","technicalDetail":"Rescinnamine acts as a competitive inhibitor of the synaptic vesicular amine transporter (SVAT), specifically targeting the transport of catecholamines such as dopamine and norepinephrine."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Rescinnamine","title":"Rescinnamine","extract":"Rescinnamine, known by the brand names Moderil, Cinnasil, and Anaprel, is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug."},"commercial":{"launchDate":"1956","_launchSource":"DrugCentral (FDA 1956-10-31, PFIZER)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2369","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=RESCINNAMINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Rescinnamine","fields":["history","overview"],"source":"Wikipedia"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T02:36:29.658413","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:02.639794+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"reserpine","drugSlug":"reserpine","fdaApproval":"1955-10-12","genericCount":17,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"deserpidine","drugSlug":"deserpidine","fdaApproval":"1957-04-19","patentStatus":"Unknown","relationship":"same-class"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"rescinnamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"reserpine","brandName":"reserpine","genericName":"reserpine","approvalYear":"1955","relationship":"same-class"},{"drugId":"deserpidine","brandName":"deserpidine","genericName":"deserpidine","approvalYear":"1957","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"_patentsChecked":true,"crossReferences":{"NUI":"N0000146941","NDDF":"000643","UNII":"Q6W1F7DJ2D","VUID":"4018628","CHEBI":"CHEBI:28572","VANDF":"4018628","INN_ID":"683","RXNORM":"9259","UMLSCUI":"C0035167","chemblId":"CHEMBL1668","ChEMBL_ID":"CHEMBL1668","KEGG_DRUG":"D00198","DRUGBANK_ID":"DB01180","PUBCHEM_CID":"5280954","SNOMEDCT_US":"2927004","IUPHAR_LIGAND_ID":"7098","MESH_SUPPLEMENTAL_RECORD_UI":"C084826"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1956-","companyName":"Pfizer","relationship":"Original Developer"}],"publicationCount":82,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"C02AA01","allCodes":["C02AA01","C02LA02","C02LA52"]},"biosimilarFilings":[],"originalDeveloper":"Pfizer","recentPublications":[{"date":"2022","pmid":"35814925","title":"In vitro evaluation of bioactive properties of banana sap.","journal":"Biologia"},{"date":"2021","pmid":"34055238","title":"Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.","journal":"Computational and structural biotechnology journal"},{"date":"2021 Apr 23","pmid":"33836128","title":"Decomposition Profile Data Analysis for Deep Understanding of Multiple Effects of Natural Products.","journal":"Journal of natural products"},{"date":"2022 Apr","pmid":"33131412","title":"Unravelling the drugability of MSI2 RNA recognition motif (RRM) protein and the prediction of their effective antileukemia inhibitors from traditional herb concoctions.","journal":"Journal of biomolecular structure & dynamics"},{"date":"2020 Dec","pmid":"29956574","title":"The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder.","journal":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry"}],"companionDiagnostics":[],"genericManufacturers":1,"_genericFilersChecked":true,"genericManufacturerList":["Panray"],"status":"approved","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"1956","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:02.639794+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}